세계의 생물제제 시장 리포트(2023년)

“Biologics Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The biologics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines

• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Other Distribtuion Channels

• 3) By Route Of Administration: Oral; Parenteral; Other Route Of Administration

• 4) By Drug Classification: Branded Drugs; Generic Drugs

• 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

• Subsegments Covered: Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Other Monoclonal Antibodies (MAbs); Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins; Anti-Infective Vaccines; Autoimmunity Vaccines; Other Vaccines

• Companies Mentioned: AbbVie; Johnson & Johnson; Amgen; Sanofi S.A; F. Hoffmann-La Roche Ltd.

• Countries: Australia, China, Bangladesh, India, Indonesia, Japan, South Korea, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, USA, Canada, Mexico, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major companies in the biologics market include: AbbVie, Johnson & Johnson, Amgen, Sanofi S.A, F. Hoffmann-La Roche Ltd., GlaxosmithKline, Novartis AG, Pfizer Inc., Teva Pharmaceuticals and CSL.

The global biologics market is expected to grow from $382.04 billion in 2022 to $416.65 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The biologics market is expected to reach $599.62 billion in 2027 at a CAGR of 9.5%.

The biologics market consists of sales of Tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses such Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials.

North America was the largest region in the biologics market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of biologics are monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are created in a laboratory to combat a specific infection. The various route of administration includes oral, parenteral, and others that are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others.

Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon's Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics. Such technological advances are likely to reduce costs and expedite the development phase of biologics, allowing companies to launch their products early.

The early generation of biologics is losing its patent protection and is expected to face greater competition going forward from the entry of biosimilars into the market. Biosimilars are pharmaceuticals that are developed to have similar properties to a biological drug that has already been approved. Demand for biosimilars is being fueled by governments around the world trying to reduce healthcare costs. In India, a new biosimilar policy called the 'Guidelines on Similar Biologics' prepared by the Central Drugs Standard Control Organization (CSDCO) is expected to give a major boost to the Indian biosimilars industry. In the EU, a pathway for approving biosimilar medicines has existed since 2003. These less expensive alternatives increase the competitiveness of the biologics market putting downward pressure on pricing and market value growth.

The US Food and Drug Administration (FDA) has revised its regulations to eliminate outdated biologics requirements, thus allowing drug manufacturers to employ new manufacturing technologies and testing capabilities. Standard preparations (standard solutions containing a precisely known concentration of an element), which help to ensure the safety, purity, and potency of biologics can now be obtained from sources other than FDA's Center for Biologics Evaluation and Research (CBER) or can be developed internally by the biologics license applicant. The FDA has also removed a rule (Section 610.21 of FDA code) that specifies minimal potency limits to be met for certain antibodies and antigens. In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics. These amendments in regulations are expected to increase regulatory flexibility by allowing the pharmaceutical industry and the FDA to incorporate current scientific technologies in the manufacture of licensed biological products.

The countries covered in the biologics market report are: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. 

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The biologics market research report is one of a series of new reports from The Business Research Company that provides biologics market statistics, including biologics industry global market size, regional shares, competitors with a biologics market share, detailed biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the biologics industry. This biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Report Structure

3. Biologics Market Characteristics

• 3.1. Market Definition
• 3.2. Key Segmentations

4. Biologics Market Product Analysis

• 4.1. Leading Products/ Services
• 4.2. Key Features and Differentiators
• 4.3. Development Products

5. Biologics Market Supply Chain

• 5.1. Supply Chain
• 5.2. Distribution
• 5.3. End Customers

6. Biologics Market Customer Information

• 6.1. Customer Preferences
• 6.2. End Use Market Size and Growth

7. Biologics Market Trends And Strategies

8. Biologics Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On Biologics Market
• 8.2 Ukraine-Russia War Impact On Biologics Market
• 8.3 Impact Of High Inflation On Biologics Market

9. Biologics Market Size And Growth

• 9.1. Market Size
• 9.2. Historic Market Growth, Value ($ Billion)
  • 9.2.1. Drivers Of The Market
  • 9.2.2. Restraints On The Market
• 9.3. Forecast Market Growth, Value ($ Billion)
  • 9.3.1. Drivers Of The Market
  • 9.3.2. Restraints On The Market

10. Biologics Market Regional Analysis

• 10.1. Global Biologics Market, 2022, By Region, Value ($ Billion)
• 10.2. Global Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Region
• 10.3. Global Biologics Market, Growth And Market Share Comparison, By Region

11. Biologics Market Segmentation

• 11.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Monoclonal Antibodies (MAbS)
• Therapeutic Proteins
• Vaccines
• 11.2. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies/ Drug Stores
• Others
• 11.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Oral
• Parenteral
• Others
• 11.4. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Branded Drugs
• Generic Drugs
• 11.5. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Prescription-Based Drugs
• Over-The-Counter Drugs

12. Biologics Market Segments

• 12.1. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion) - Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Other Monoclonal Antibodies (MAbs)
• 12.2. Global Therapeutic Proteins Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion) - Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins
• 12.3. Global Vaccines Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion) - Anti-Infective Vaccines; Autoimmunity Vaccines; Other Vaccines

13. Biologics Market Metrics

• 13.1. Biologics Market Size, Percentage Of GDP, 2017-2027, Global
• 13.2. Per Capita Average Biologics Market Expenditure, 2017-2027, Global

14. Asia-Pacific Biologics Market

• 14.1. Asia-Pacific Biologics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Asia-Pacific, Biologics Market, 2022, By Country, Value ($ Billion)
• 14.3. Asia-Pacific, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
• 14.4. Asia-Pacific, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
• 14.5. Asia-Pacific, Biologics Market Metrics
  • 14.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Asia-Pacific Countries
  • 14.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Asia-Pacific Countries
  • 14.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Asia-Pacific Countries
• 14.6. Asia-Pacific Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
• 14.7. Asia-Pacific Biologics Market: Country Analysis
  • 14.7.1. China Biologics Market
    • 14.7.1.1. China Biologics Market Overview
    • 14.7.1.2. China Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.1.3. China Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.2. Australia Biologics Market
    • 14.7.2.1. Australia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.2.2. Australia Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.3. Hong Kong Biologics Market
    • 14.7.3.1. Hong Kong Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.4. India Biologics Market
    • 14.7.4.1. India Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.4.2. India Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.5. Indonesia Biologics Market
    • 14.7.5.1. Indonesia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.5.2. Indonesia Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.6. Japan Biologics Market
    • 14.7.6.1. Japan Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.6.2. Japan Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.7. Malaysia Biologics Market
    • 14.7.7.1. Malaysia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.8. New Zealand Biologics Market
    • 14.7.8.1. New Zealand Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.9. Philippines Biologics Market
    • 14.7.9.1. Philippines Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.10. Singapore Biologics Market
    • 14.7.10.1. Singapore Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.11. South Korea Biologics Market
    • 14.7.11.1. South Korea Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.11.2. South Korea Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.12. Thailand Biologics Market
    • 14.7.12.1. Thailand Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.13. Vietnam Biologics Market
    • 14.7.13.1. Vietnam Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7.14. Bangladesh Biologics Market
    • 14.7.14.1. Bangladesh Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

15. Western Europe Biologics Market

• 15.1. Western Europe Biologics Market Overview
• 15.2. Western Europe, Biologics Market, 2022, By Country, Value ($ Billion)
• 15.3. Western Europe, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
• 15.4. Western Europe, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
• 15.5. Western Europe, Biologics Market Metrics
  • 15.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Western Europe Countries
  • 15.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Western Europe Countries
  • 15.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Western Europe Countries
• 15.6. Western Europe Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
• 15.7. Western Europe Biologics Market: Country Analysis
  • 15.7.1. Austria Biologics Market
    • 15.7.1.1. Austria Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.2. Belgium Biologics Market
    • 15.7.2.1. Belgium Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.3. Denmark Biologics Market
    • 15.7.3.1. Denmark Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.4. Finland Biologics Market
    • 15.7.4.1. Finland Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.5. France Biologics Market
    • 15.7.5.1. France Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.5.2. France Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.6. Germany Biologics Market
    • 15.7.6.1. Germany Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.6.2. Germany Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.7. Ireland Biologics Market
    • 15.7.7.1. Ireland Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.8. Italy Biologics Market
    • 15.7.8.1. Italy Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.9. Netherlands Biologics Market
    • 15.7.9.1. Netherlands Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.10. Norway Biologics Market
    • 15.7.10.1. Norway Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.11. Portugal Biologics Market
    • 15.7.11.1. Portugal Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.12. Spain Biologics Market
    • 15.7.12.1. Spain Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.13. Sweden Biologics Market
    • 15.7.13.1. Sweden Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.15. Switzerland Biologics Market
    • 15.7.15.1. Switzerland Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7.15. UK Biologics Market
    • 15.7.15.1. UK Biologics Market2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.15.2. UK Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

16. Eastern Europe Biologics Market

• 16.1. Eastern Europe Biologics Market Overview
• 16.2. Eastern Europe, Biologics Market, 2022, By Country, Value ($ Billion)
• 16.3. Eastern Europe, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
• 16.4. Eastern Europe, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
• 16.5. Eastern Europe, Biologics Market Metrics
  • 16.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Eastern Europe Countries
  • 16.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Eastern Europe Countries
  • 16.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Eastern Europe Countries
• 16.6. Eastern Europe Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
• 16.7. Eastern Europe Biologics Market: Country Analysis
  • 16.7.1. Czech Republic Biologics Market,
    • 16.7.1.1. Czech Republic Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 16.7.2. Poland Biologics Market
    • 16.7.2.1. Poland Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 16.7.3. Romania Biologics Market
    • 16.7.3.1. Romania Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 16.7.4. Russia Biologics Market
    • 16.7.4.1. Russia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 16.7.4.2. Russia Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 16.7.5. Ukraine Biologics Market
    • 16.7.5.1. Ukraine Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

17. North America Biologics Market

• 17.1. North America Biologics Market Overview
• 17.2. North America, Biologics Market, 2022, By Country, Value ($ Billion)
• 17.3. North America, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
• 17.4. North America, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
• 17.5. North America, Biologics Market Metrics
  • 17.5.1. Per Capita Average Biologics Expenditure, 2017-2027, North America Countries
  • 17.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, North America Countries
  • 17.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, North America Countries
• 17.6. North America Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
• 17.7. North America Biologics Market: Country Analysis
  • 17.7.1. Canada Biologics Market
    • 17.7.1.1. Canada Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 17.7.2. Mexico Biologics Market
    • 17.7.2.1. Mexico Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 17.7.3. USA Biologics Market
    • 17.7.3.1. USA Biologics Market Overview
    • 17.7.3.2. USA Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 17.7.3.3. USA Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

18. South America Biologics Market

• 18.1. South America Biologics Market Overview
• 18.2. South America, Biologics Market, 2022, By Country, Value ($ Billion)
• 18.3. South America, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
• 18.4. South America, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
• 18.5. South America, Biologics Market Metrics
  • 18.5.1. Per Capita Average Biologics Expenditure, 2017-2027, South America Countries
  • 18.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, South America Countries
  • 18.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, South America Countries
• 18.6. South America Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
• 18.7. South America Biologics Market: Country Analysis
  • 18.7.1. Argentina Biologics Market
    • 18.7.1.1. Argentina Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 18.7.2. Brazil Biologics Market
    • 18.7.1.1. Brazil Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 18.7.2.2. Brazil Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 18.7.3. Chile Biologics Market
    • 18.7.3.1. Chile Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 18.7.4. Colombia Biologics Market
    • 18.7.4.1. Colombia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 18.7.5. Peru Biologics Market
    • 18.7.5.1. Peru Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 18.7.6. Venezuela Biologics Market
    • 18.7.6.1. Venezuela Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

19. Middle East Biologics Market

• 19.1. Middle East Biologics Market Overview
• 19.2. Middle East, Biologics Market, 2022, By Country, Value ($ Billion)
• 19.3. Middle East, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
• 19.4. Middle East, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
• 19.5. Middle East, Biologics Market Metrics
  • 19.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Middle East Countries
  • 19.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Middle East Countries
  • 19.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Middle East Countries
• 19.6. Middle East Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
• 19.7. Middle East Biologics Market: Country Analysis
  • 19.7.1. Saudi Arabia Biologics Market
    • 19.7.1.1. Saudi Arabia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 19.7.2. Israel Biologics Market
    • 19.7.2.1. Israel Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 19.7.3. Turkey Biologics Market
    • 19.7.3.1. Turkey Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 19.7.4. UAE Biologics Market
    • 19.7.4.1. UAE Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

20. Africa Biologics Market

• 20.1. Africa Biologics Market Overview
• 20.2. Africa, Biologics Market, 2022, By Country, Value ($ Billion)
• 20.3. Africa, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
• 20.4. Africa, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
• 20.5. Africa, Biologics Market Metrics
  • 20.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Africa Countries
  • 20.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Africa Countries
  • 20.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Africa Countries
• 20.6. Africa Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
• 20.7. Africa Biologics Market: Country Analysis
  • 20.7.1. Egypt Biologics Market
    • 20.7.1.1. Egypt Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 20.7.2. Nigeria Biologics Market
    • 20.7.2.1. Nigeria Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 20.7.3. South Africa Biologics Market
    • 20.7.3.1. South Africa Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

21. Biologics Market Competitive Landscape

• 21.1. Competitive Market Overview
• 21.2. Market Shares
• 21.3. Company Profiles
  • 21.3.1. AbbVie
    • 21.3.1.1. Company Overview
    • 21.3.1.2. Products And Services
    • 21.3.1.3. Strategy
    • 21.3.1.4. Financial Performance
  • 21.3.2. Johnson & Johnson
    • 21.3.2.1. Company Overview
    • 21.3.2.2. Products And Services
    • 21.3.2.3. Strategy
    • 21.3.2.4. Financial Performance
  • 21.3.3. Amgen
    • 21.3.3.1. Company Overview
    • 21.3.3.2. Products And Services
    • 21.3.3.3. Strategy
    • 21.3.3.4. Financial Performance
  • 21.3.4. Sanofi S.A
    • 21.3.4.1. Company Overview
    • 21.3.4.2. Products And Services
    • 21.3.4.3. Strategy
    • 21.3.4.4. Financial Performance
  • 21.3.5. F. Hoffmann-La Roche Ltd
    • 21.3.5.1. Company Overview
    • 21.3.5.2. Products And Services
    • 21.3.5.3. Strategy
    • 21.3.5.4. Financial Performance

22. Key Mergers And Acquisitions In The Biologics Market

23. Market Background: Pharmaceuticals Market

• 23.1. Pharmaceuticals Market Characteristics
• 23.2. Pharmaceuticals Market Historic and Forecast, 2017-2022, 2022-2027F, 2032F Growth, By Segment, Value ($ Billion), Global
• 23.3. Global Pharmaceuticals Market, 2022, By Region, Value ($ Billion)
• 23.4. Global Pharmaceuticals Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Region
• 23.5. Global Pharmaceuticals Market, 2017-2022, 2022-2027F, 2032F, Segmentation By Type, Value ($ Billion)

24. Recommendations

• 24.1. Global Biologics Market In 2027- Growth Countries
• 24.2. Global Biologics Market In 2027- Growth Segments
• 24.3. Global Biologics Market In 2027- Growth Strategies

25. Appendix

• 25.1. NAICS Definitions Of Industry Covered In This Report
• 25.2. Abbreviations
• 25.3. Currencies
• 25.4. Historic And Forecast Inflation Rates
• 25.5. Research Inquiries
• 25.6. The Business Research Company
• 25.7. Copyright And Disclaimer